Skip to content

The application of TSPO-PET in diagnosis of autoimmune encephalitis

The application of TSPO-PET in diagnosis of autoimmune encephalitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066922
Enrollment
Unknown
Registered
2022-12-21
Start date
2022-01-24
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune encephalitis

Interventions

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: AE patients 1) Diagnosed as antibody-positive autoimmune encephalitis according to clinical guidelines or diagnostic criteria; 2) Age from 18 years old to 80 years old, without sex restriction; 3) Promise to complete the study and follow-up as planned, and the patient and/or guardian (when the patient is unconscious) can understand the study and sign the informed consent form. Healthy control 1) No previous history of encephalitis and family history related to encephalitis; 2) No obvious abnormality was found in physical examination.

Exclusion criteria

Exclusion criteria: Exclusion criteria for AE patients: 1) Diagnosed diseases of the central nervous system that lead to epilepsy, cognitive impairment or abnormal mental symptoms, including Alzheimer's disease, Parkinson's disease, central nervous system tumors, schizophrenia, etc, in recent 5 years. Patients with other system tumor diseases should not be excluded; 2) Lactating and/or pregnant women; 3) History of brain surgery; 4) Patients with serious medical diseases (such as heart, liver, lung and kidney insufficiency); 5) Patients unable to cooperate with the examination due to severe mental and behavioral abnormalities, central respiratory failure, etc; 6) The researchers believe that the subjects may not be able to complete the study or may not be able to comply with the requirements of the study; Healthy control 1) Diagnosed diseases of the central nervous system that lead to epilepsy, cognitive impairment or abnormal mental symptoms, including Alzheimer's disease, Parkinson's disease, central nervous system tumors, schizophrenia, etc, in recent 5 years. 2) Suffering from tumor disease; 3) People with severe liver and kidney dysfunction, cardiopulmonary failure, blood system diseases, and severe systemic infectious diseases; 4) Suffering from mental illness. 5) The researchers believe that the subjects may not be able to complete the study or may not be able to comply with the requirements of the study.

Design outcomes

Primary

MeasureTime frame
Sensitivity;

Secondary

MeasureTime frame
Specificity;SUVmean of TSPO;Correlation between TSPO and FDG uptake;

Countries

China

Contacts

Public ContactYong Hao
yonghao23@126.com21 68383072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026